You are here:Home-Chemical Inhibitors & Agonists-Cell Cycle/DNA Damage-Cyclin-dependent Kinase (CDK)

Request The Product List ofCyclin-dependent Kinase (CDK) Cyclin-dependent Kinase (CDK)

Cat. No. Product Name Information
PC-38758

Zotiraciclib

CDK/JAK2/FLT3 inhibitor

Zotiraciclib (TG02, SB1317) is a potent multi-kinase inhibitor of cyclin dependent kinases (CDKs), JAK2, and FLT3 with IC50of 13, 73, and 56 nM for CDK2, JAK2 and FLT3, respectively.
PC-38750

ZNL-05-044

CDK11 inhibitor

ZNL-05-044 is a potent, selective CDK11 inhibitor with Kd of 69 nM (CDK11A), shows significantly kinome-wide selectivity.
PC-38645

Cimpuciclib

CDK inhibitor

Cimpuciclib is a cyclin-dependent kinase(CDK) inhibitor with antineoplastic activity.
PC-38355

Dalpiciclib

CDK4/6 inhibitor

Dalpiciclib (SHR6390) is an orally bioavailable, small molecule CDK4/6 inhibitor, strongly inhibits tumor proliferation of ESCC in vitro and in vivo.
PC-38340

Avotaciclib

CDK1 inhibitor

Avotaciclib (BEY1107) is a potent, selective CDK1 (Cyclin-Dependent Kinase 1) inhibitor, inhibits self-replication of cancer stem cells and is a candidate for pancreatic cancer treatment.
PC-73446

Tanuxiciclib

CDK inhibitor

Tanuxiciclib is a potent cyclin dependent kinase (CDK) inhibitor.
PC-73414

Eciruciclib

CDK inhibitor

Eciruciclib is a potent cyclin dependent kinase (CDK) inhibitor with antineoplastic activities.
PC-73257

ASP9822

CDK7 inhibitor

ASP9822 is a novel potent selective CDK7 inhibitor with IC50 of 4.3 nM, with anti-cancer activity.
PC-73186

NCT02

CCNK-CDK12 degrader

NCT02 is a small moelcule that induces ubiquitination of cyclin K (CCNK) and proteasomal degradation of CCNK and its complex partner CDK12.
PC-73102

SR4835

CDK12/13 inhibitor

SR-4835 (SR4835) is a potent, highly selective dual inhibitor of CDK12 and CDK13 with IC50 of 98 and 4.9 nM, respectively.
PC-72894

GFB-12811

CDK5 inhibitor

GFB-12811 (GFB12811) is a potent, highly selective CDK5 inhibitor with IC50 of 2.3 nM.
PC-72777

SY-5609

CDK7 inhibitor

SY-5609 (SY5609) is a highly potent, selective, noncovalent and orally available inhibitor of CDK7 with Kd of 0.07 nM in SPR assays (binding to CDK7/Cyclin H).

Request The Product List

* Indicates a Required FieldYour information is safe with us.

  • *Product List:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Country:
  • Additional Information:

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com